Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Peter Schlingmann

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Human Mutation|February 18, 2021
The phenotypic and genetic spectrum of patients with heterozygous mutations in cyclin M2 (CNNM2)Gijs A C Franken, Dominik Müller, Cyril Mignot, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosisDebayan Dasgupta, Mark J Wee, Monica Reyes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 15, 2023
Withdrawn as duplicate: Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature reviewHeidi Schigt, Martin Bald, Bram C J van der Eerden, et al.
Kidney International Reports|October 27, 2025
Novel <i>RRAGD</i> Variants in Autosomal Dominant Kidney Hypomagnesemia and Therapeutic PerspectivesAnastasia Adella, François Jouret, Leire Madariaga, et al.
Kidney International Reports|September 12, 2022
Refining Kidney Survival in 383 Genetically Characterized Patients With NephronophthisisJens Christian König, Rebeka Karsay, Joachim Gerß, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2026
Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumabIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin DLaura Celine Brieger, Stephan Przygodda, Alina Verena Bohlen, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2026
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin DStephan Przygodda, Laura Celine Brieger, Alina Verena Bohlen, et al.
Kidney International Reports|November 24, 2025
Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman SyndromeMichiel L A J Wieërs, Lise Allard, Viola D'Ambrosio, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Human Mutation|February 18, 2021
The phenotypic and genetic spectrum of patients with heterozygous mutations in cyclin M2 (CNNM2)Gijs A C Franken, Dominik Müller, Cyril Mignot, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosisDebayan Dasgupta, Mark J Wee, Monica Reyes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 15, 2023
Withdrawn as duplicate: Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature reviewHeidi Schigt, Martin Bald, Bram C J van der Eerden, et al.
Kidney International Reports|October 27, 2025
Novel <i>RRAGD</i> Variants in Autosomal Dominant Kidney Hypomagnesemia and Therapeutic PerspectivesAnastasia Adella, François Jouret, Leire Madariaga, et al.
Kidney International Reports|September 12, 2022
Refining Kidney Survival in 383 Genetically Characterized Patients With NephronophthisisJens Christian König, Rebeka Karsay, Joachim Gerß, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2026
Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumabIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin DLaura Celine Brieger, Stephan Przygodda, Alina Verena Bohlen, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2026
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin DStephan Przygodda, Laura Celine Brieger, Alina Verena Bohlen, et al.
Kidney International Reports|November 24, 2025
Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman SyndromeMichiel L A J Wieërs, Lise Allard, Viola D'Ambrosio, et al.
Pageof 4